CD8A and colorectal carcinoma: Recent RCTs indicate that multi-strain probiotics may enhance immunotherapy responsiveness by improving antigen presentation and CD8+ T cell activity, yet whether such immune modulation translates into CRC prevention in diabetics is unknown [89].